Kathryn Gold
MD
Associate Professor of Medicine
👥Biography 个人简介
Kathryn Gold leads HER2-directed NSCLC trials at UC San Diego including key T-DXd studies, contributing to the regulatory approval of T-DXd for HER2-mutant NSCLC. Her work addresses HER2 amplification and protein overexpression as distinct biomarkers from mutation. She promotes standardized HER2 testing workflows in thoracic oncology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Kathryn Gold 的研究动态
Follow Kathryn Gold's research updates
留下邮箱，当我们发布与 Kathryn Gold（UC San Diego Moores Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment